{
    "organizations": [],
    "uuid": "1b3518c20d88f3bf7811aae35bc375c3dad4187c",
    "author": "",
    "url": "https://www.reuters.com/article/brief-pacific-biosciences-prevails-in-pa/brief-pacific-biosciences-prevails-in-patent-eligibility-ruling-idUSFWN1R4125",
    "ord_in_thread": 0,
    "title": "BRIEF-Pacific Biosciences Prevails In Patent Eligibility Ruling",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 22, 2018 / 9:05 PM / Updated 11 minutes ago BRIEF-Pacific Biosciences Prevails In Patent Eligibility Ruling Reuters Staff March 22 (Reuters) - Pacific Biosciences Of California Inc : * PACIFIC BIOSCIENCES PREVAILS IN PATENT ELIGIBILITY RULING AGAINST OXFORD NANOPORE * PACIFIC BIOSCIENCES - U.S. DISTRICT COURT DENIED A MOTION TO DISMISS FILED ON DEC 14, 2017 BY UNIT OF OXFORD NANOPORE TECHNOLOGIES LTDâ€‹ Source text for Eikon: Further company coverage:",
    "published": "2018-03-22T23:04:00.000+02:00",
    "crawled": "2018-03-22T23:28:01.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "bioscience",
        "prevails",
        "patent",
        "eligibility",
        "ruling",
        "reuters",
        "staff",
        "march",
        "reuters",
        "pacific",
        "bioscience",
        "california",
        "inc",
        "pacific",
        "bioscience",
        "prevails",
        "patent",
        "eligibility",
        "ruling",
        "oxford",
        "nanopore",
        "pacific",
        "bioscience",
        "district",
        "court",
        "denied",
        "motion",
        "dismiss",
        "filed",
        "dec",
        "unit",
        "oxford",
        "nanopore",
        "technology",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}